CMD Cantel Medical Corp

CRITICARE SYSTEMS, INC. (AMEX:CMD). Criticare Systems, Inc. today announced it had reached an agreement with Nellcor Puritan Bennett Incorporated to provide a non-exclusive license for a patent held by Criticare Systems. The patent encompasses a signal processing technology developed by Criticare Systems. Specific financial and other terms were not disclosed. Criticare Systems has a substantial library of proprietary and patent protected technology relating to vital signs monitoring. This has enabled the company to successfully develop a wide variety of instrumentation ranging from complex anesthetic agent monitoring to systems that can operate within the high intensity magnetic field of an MRI suite. Criticare Systems continues to provide innovative monitoring solutions to support the advancement of healthcare. Criticare (www.csiusa.com) designs, manufactures, and markets cost-effective patient monitoring systems and noninvasive sensors for a wide range of hospitals and alternate health care environments throughout the world. This press release contains forward-looking statements. Such statements refer to the Company's beliefs and expectations. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those described. Such uncertainties include, but are not limited to, the timely completion of new products, regulatory approvals for new products, the risk of new and better technologies, risks relating to international markets, as well as general conditions and competition in the company's markets. Other risks are set forth in Criticare's reports and documents filed from time to time with the Securities and Exchange Commission.